FDA Inspection 762210 — PharmaZell GmbH
The FDA completed an inspection of PharmaZell GmbH on December 8, 2011 in Raubling. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 8, 2011
- Fiscal Year
- 2012
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Raubling (Germany)